DOCHERTY JOHN MARTIN 4
4 · Lexaria Bioscience Corp. · Filed Feb 12, 2020
Insider Transaction Report
Form 4
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
- Award
Stock Options
2020-02-07+550,000→ 1,250,000 totalExercise: $0.47From: 2020-02-07Exp: 2025-02-07→ Common Shares (550,000 underlying)
Holdings
- 1,622,250(indirect: Private Holding Company)
common shares
- 300,000
Stock Options
Exercise: $0.11From: 2016-04-15Exp: 2021-04-15→ Common Shares (300,000 underlying) - 700,000
Stock Options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (400,000 underlying)